Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
$260M |
| 2 |
Y
Alleghany Corporation
Y
|
$139M |
| 3 |
FBC
Flagstar Bancorp, Inc. New
FBC
|
$137M |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
$121M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
$86.4M |
Sector Composition
| 1 | Financials | 15.11% |
| 2 | Technology | 12.49% |
| 3 | Industrials | 10.78% |
| 4 | Healthcare | 9.96% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Veritone
VERI
$147M
| $97 | ﹤0.01% |
+18,241
| New | +$97 |
|
|
ATON
3327
AlphaTON Capital Corp. Common Stock
ATON
$11.6M
| $96 | ﹤0.01% |
916
+132
| +17% | +$14 |
|
3328
Black Diamond Therapeutics
BDTX
$167M
| $95 | ﹤0.01% |
52,522
-7,524
| -13% | -$14 |
|
3329
McEwen Inc.
MUX
$734M
| $94 | ﹤0.01% |
15,954
+8
| +0.1% | – |
|
3330
Dakota Gold
DC
$499M
| $92 | ﹤0.01% |
+30,096
| New | +$92 |
|
3331
Sabre
SABR
$675M
| $92 | ﹤0.01% |
14,952
+408
| +3% | +$3 |
|
3332
CorMedix
CRMD
$926M
| $91 | ﹤0.01% |
21,601
+16
| +0.1% | – |
|
|
IRD
3333
Opus Genetics, Inc. Common Stock
IRD
$76.1M
| $91 | ﹤0.01% |
25,592
+16
| +0.1% | – |
|
|
CFMS
3334
DELISTED
Conformis, Inc. Common Stock
CFMS
| $91 | ﹤0.01% |
+27,266
| New | +$91 |
|
3335
Anixa Biosciences
ANIX
$95.7M
| $90 | ﹤0.01% |
21,177
| – | – |
|
3336
CPS Technologies
CPSH
$48.8M
| $90 | ﹤0.01% |
33,583
| – | – |
|
3337
CEL-SCI Corp
CVM
$72.2M
| $90 | ﹤0.01% |
1,273
+406
| +47% | +$29 |
|
3338
Beyond Air
XAIR
$11.5M
| $90 | ﹤0.01% |
+690
| New | +$90 |
|
3339
Dolphin Entertainment
DLPN
$14.1M
| $89 | ﹤0.01% |
24,650
-2,622
| -10% | -$9 |
|
3340
Eventbrite
EB
$254M
| $89 | ﹤0.01% |
+15,200
| New | +$89 |
|
|
VXRT
3341
DELISTED
Vaxart
VXRT
| $88 | ﹤0.01% |
91,095
| – | – |
|
3342
Biomerica
BMRA
$7.74M
| $87 | ﹤0.01% |
3,259
| – | – |
|
3343
Houston American Energy
HUSA
$252M
| $87 | ﹤0.01% |
2,538
+559
| +28% | +$19 |
|
3344
Advantage Solutions
ADV
$580M
| $85 | ﹤0.01% |
+40,994
| New | +$85 |
|
3345
Athira Pharma
ATHA
$15.4M
| $85 | ﹤0.01% |
26,881
+5,986
| +29% | +$19 |
|
3346
Bioventus
BVS
$481M
| $83 | ﹤0.01% |
31,863
-6,286
| -16% | -$16 |
|
|
LGO
3347
Largo
LGO
$95.6M
| $83 | ﹤0.01% |
15,301
-2,271
| -13% | -$12 |
|
|
UBX
3348
DELISTED
Unity Biotechnology
UBX
| $83 | ﹤0.01% |
+30,426
| New | +$83 |
|
3349
8x8 Inc
EGHT
$282M
| $82 | ﹤0.01% |
+18,906
| New | +$82 |
|
3350
Medallion Financial
MFIN
$249M
| $82 | ﹤0.01% |
11,451
| – | – |
|